Zhenxing Tu

1.1k total citations
23 papers, 973 citations indexed

About

Zhenxing Tu is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Zhenxing Tu has authored 23 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Surgery and 5 papers in Oncology. Recurrent topics in Zhenxing Tu's work include Virus-based gene therapy research (4 papers), Cancer Research and Treatments (4 papers) and Sphingolipid Metabolism and Signaling (4 papers). Zhenxing Tu is often cited by papers focused on Virus-based gene therapy research (4 papers), Cancer Research and Treatments (4 papers) and Sphingolipid Metabolism and Signaling (4 papers). Zhenxing Tu collaborates with scholars based in China, United States and Germany. Zhenxing Tu's co-authors include Sarah Spiegel, Ana Olivera, Takafumi Kohama, James R. Van Brocklyn, Lisa C. Edsall, Ramil Menzeleev, Sheldon Milstien, Richard R. Schmidt, James R. Broach and Suzanne Mandala and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Zhenxing Tu

23 papers receiving 953 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenxing Tu China 10 765 370 116 106 79 23 973
Mujun Zhao China 17 663 0.9× 202 0.5× 158 1.4× 275 2.6× 84 1.1× 38 1.1k
Carmen De Lemos-Chiarandini United States 11 599 0.8× 575 1.6× 131 1.1× 55 0.5× 60 0.8× 12 913
Yan Shan Ong Singapore 8 482 0.6× 398 1.1× 86 0.7× 65 0.6× 41 0.5× 9 699
Carlos A. Torres‐Ramos United States 15 1.1k 1.5× 116 0.3× 76 0.7× 87 0.8× 29 0.4× 21 1.4k
Alain Pauloin France 15 460 0.6× 423 1.1× 47 0.4× 47 0.4× 52 0.7× 34 746
Ryo Ushioda Japan 12 587 0.8× 690 1.9× 80 0.7× 278 2.6× 137 1.7× 22 1.0k
Jonathan D. Gary United States 10 1.8k 2.4× 655 1.8× 160 1.4× 156 1.5× 45 0.6× 10 2.2k
Tomás Aragón Spain 14 667 0.9× 752 2.0× 63 0.5× 372 3.5× 80 1.0× 23 1.2k
Pingzhao Zhang China 24 1.1k 1.4× 264 0.7× 75 0.6× 136 1.3× 144 1.8× 54 1.4k
Kelly M. Weixel United States 17 505 0.7× 431 1.2× 96 0.8× 51 0.5× 64 0.8× 22 889

Countries citing papers authored by Zhenxing Tu

Since Specialization
Citations

This map shows the geographic impact of Zhenxing Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenxing Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenxing Tu more than expected).

Fields of papers citing papers by Zhenxing Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenxing Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenxing Tu. The network helps show where Zhenxing Tu may publish in the future.

Co-authorship network of co-authors of Zhenxing Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenxing Tu. A scholar is included among the top collaborators of Zhenxing Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenxing Tu. Zhenxing Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yunhan, Zhenxing Tu, Mimi L.K. Tang, et al.. (2025). Enhanced mucosal immune response through nanoparticle delivery system based on chitosan-catechol and a recombinant antigen targeted towards M cells. International Journal of Biological Macromolecules. 306(Pt 1). 141345–141345. 2 indexed citations
2.
Du, Gaoming, et al.. (2022). An Area-Efficient Large Integer NTT-Multiplier Using Discrete Twiddle Factor Approach. IEEE Transactions on Circuits & Systems II Express Briefs. 70(2). 751–755. 7 indexed citations
3.
Du, Gaoming, et al.. (2022). A BNN Accelerator Based on Edge-skip-calculation Strategy and Consolidation Compressed Tree. ACM Transactions on Reconfigurable Technology and Systems. 15(3). 1–20. 4 indexed citations
4.
Tu, Zhenxing, et al.. (2021). Blood lipids and risk of colon or rectal cancer: a Mendelian randomization study. Journal of Cancer Research and Clinical Oncology. 147(12). 3591–3599. 11 indexed citations
5.
Tu, Zhenxing, et al.. (2021). Identifying modifiable risk factors of lung cancer: Indications from Mendelian randomization. PLoS ONE. 16(10). e0258498–e0258498. 9 indexed citations
6.
He, Xiaoping, Changqing Su, Xinghua Wang, et al.. (2009). E1B-55kD-deleted oncolytic adenovirus armed with canstatin gene yields an enhanced anti-tumor efficacy on pancreatic cancer. Cancer Letters. 285(1). 89–98. 30 indexed citations
7.
Li, Zhao‐Shen, Xiao‐Ping He, Zhenxing Tu, et al.. (2005). [Cloning of Human canstatin gene and expression of its recombinant protein].. PubMed. 27(5). 587–91. 2 indexed citations
8.
Pan, Xue, Zhaoshen Li, XU Guoming, Long Cui, & Zhenxing Tu. (2003). Adenovirus-Mediated Gene Transfer in the Treatment of Pancreatic Cancer. Pancreas. 26(3). 274–278. 6 indexed citations
9.
Liu, Feng, Zhaoshen Li, Zhenxing Sun, et al.. (2003). Detection of K-ras gene mutation at codon 12 by pancreatic duct brushing for pancreatic cancer.. PubMed. 2(2). 313–7. 5 indexed citations
10.
Li, Zhao‐Shen, et al.. (2003). Killing effects of cytosine deaminase gene mediated by adenovirus vector on human pancreatic cancer cell lines in vitro.. PubMed. 2(1). 147–51. 5 indexed citations
11.
Nie, Shinan, et al.. (2002). [Role of the pS(2) in gastric mucosa adaptative cytoprotection from stress].. PubMed. 82(3). 172–5. 3 indexed citations
12.
Pan, Xue, Zhaoshen Li, XU Guoming, et al.. (2002). Adenoviral mediated suicide gene transfer in the treatment of pancreatic cancer.. PubMed. 115(8). 1205–8. 2 indexed citations
13.
Tu, Zhenxing. (2000). The distribution and significance of cag pathogenicity island of Helicobacter pylori isolated from Chinese patients. 1 indexed citations
14.
Tu, Zhenxing, et al.. (2000). Helicobacter pylori vacA genotypes and cagA status and their relationship to associated diseases.. PubMed. 6(4). 605–607. 24 indexed citations
15.
Brocklyn, James R. Van, Zhenxing Tu, Lisa C. Edsall, Richard R. Schmidt, & Sarah Spiegel. (1999). Sphingosine 1-Phosphate-induced Cell Rounding and Neurite Retraction Are Mediated by the G Protein-coupled Receptor H218. Journal of Biological Chemistry. 274(8). 4626–4632. 167 indexed citations
16.
Olivera, Ana, Takafumi Kohama, Zhenxing Tu, Sheldon Milstien, & Sarah Spiegel. (1998). Purification and Characterization of Rat Kidney Sphingosine Kinase. Journal of Biological Chemistry. 273(20). 12576–12583. 196 indexed citations
17.
Spiegel, Sarah, Olivier Cuvillier, Lisa C. Edsall, et al.. (1998). Sphingosine‐1‐Phosphate in Cell Growth and Cell Deatha. Annals of the New York Academy of Sciences. 845(1). 11–18. 188 indexed citations
18.
Mandala, Suzanne, Rosemary Thornton, Zhenxing Tu, et al.. (1998). Sphingoid base 1-phosphate phosphatase: A key regulator of sphingolipid metabolism and stress response. Proceedings of the National Academy of Sciences. 95(1). 150–155. 216 indexed citations
19.
Stemler, M., Thomas Weimer, Zhenxing Tu, et al.. (1990). Mapping of B-cell epitopes of the human hepatitis B virus X protein. Journal of Virology. 64(6). 2802–2809. 53 indexed citations
20.
Weimer, Thomas, et al.. (1989). Immunogenicity of human hepatitis B virus P-gene derived proteins.. The Journal of Immunology. 143(11). 3750–3756. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026